AFP Testing Market By Cancer Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

AFP Testing Market
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021)
Report Code : HCR 0109
Published: 22 January, 2016   No. of pages: 145

  • Report Description
  • Table of Contents
  • Customization Options
An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It’s usually part of what’s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. The yolk sac and immature liver of an unborn baby produce AFP which then circulates through the fetal and maternal blood. Infants usually have higher levels of AFP protein which falls to normal adult level by the end of first year. AFP tests are commercially available and widely used for testing various cancer related test. AFP market is expected to increase due to increasing awareness towards cancer and globally increasing incidences of cancer and related illnesses which is also driving cancer diagnostic segment globally and is growing exponentially with huge expenditure being done on research and development activities being carried out to discover new techniques and specific antigens to further enhance the treatment mode

This report identifies the AFP Testing market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to AFP Testing market.

AFP Testing Market

Globally AFP Testing market is expected to witness growth in the upcoming future due to increasing cancer awareness and growing number of geriatric population which are more susceptible to cancer. North America represents the highest market share in the global AFP Testing market followed by Europe and Asia-Pacific with the second and third highest market share amongst all the major regions.

This market research report on global alpha-fetoprotein (AFP) Testing market is segmented based on the cancer type, as follows: Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer and Others (Cirrhosis, and Hepatitis)

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for alpha-fetoprotein in each of the region.

This report identifies all the major companies operating in the AFP Testing market. Some of the major companies’ profiles in detail are as follows:
  • Abott Laboratories
  • Becton Dickinson 
  • Biomedical Diagnostics
  • Bio-Rad Laboratories
  • Beckman Coulter 
  • Roche Diagnostics 
1. AFP Testing – Market Overview
2. Executive Summary
3. 
AFP Testing Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. AFP Testing – Market Forces
   4.1. Drivers
      4.1.1. Increasing awareness amongst people about cancers
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. AFP Testing Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global AFP Testing Market - By Cancer Type
   6.1. Liver Cancer
   6.2. Testes Cancer
   6.3. Ovarian Cancer
   6.4. Biliary Tract Cancer
   6.5. Stomach Cancer
   6.6. Pancreatic Cancer
   6.7. Others (Cirrhosis, and Hepatitis)
7. Global AFP Testing Market - By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. AFP Testing – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. Abott Laboratories
      9.1.1.  Introduction
      9.1.2. Financials
      9.1.3. Key Insights
      9.1.4. Key Strategy
      9.1.5. Product Portfolio
      9.1.6. SWOT Analysis
   9.2. Becton Dickinson 
      9.2.1. Introduction
      9.2.2. Financials
      9.2.3. Key Insights
      9.2.4. Key Strategy
      9.2.5. Product Portfolio
      9.2.6. SWOT Analysis
   9.3. Biomedical Diagnostics
      9.3.1.  Introduction
      9.3.2. Financials
      9.3.3. Key Insights
      9.3.4. Key Strategy
      9.3.5. Product Portfolio
      9.3.6. SWOT Analysis
   9.4. Bio-Rad Laboratories
      9.4.1. Introduction
      9.4.2. Financials
      9.4.3. Key Insights
      9.4.4. Key Strategy
      9.4.5. Product Portfolio
      9.4.6. SWOT Analysis
   9.5. Beckman Coulter 
      9.5.1. Introduction
      9.5.2. Financials
      9.5.3. Key Insights
      9.5.4. Key Strategy
      9.5.5. Product Portfolio
      9.5.6. SWOT Analysis
   9.6. Roche Diagnostics 
      9.6.1. Introduction
      9.6.2. Financials
      9.6.3. Key Insights
      9.6.4. Key Strategy
      9.6.5. Product Portfolio
      9.6.6. SWOT Analysis
   9.7. Kreatech Diagnostics
      9.7.1. Introduction
      9.7.2. Financials
      9.7.3. Key Insights
      9.7.4. Key Strategy
      9.7.5. Product Portfolio
      9.7.6. SWOT Analysis
   9.8. Mackay Life Sciences
      9.8.1. Introduction
      9.8.2. Financials
      9.8.3. Key Insights
      9.8.4. Key Strategy
      9.8.5. Product Portfolio
      9.8.6. SWOT Analysis
   9.9. Siemens Healthcare
      9.9.1. Introduction
      9.9.2. Financials
      9.9.3. Key Insights
      9.9.4. Key Strategy
      9.9.5. Product Portfolio
      9.9.6. SWOT Analysis
   9.10. Panacea Pharmaceuticals
      9.10.1.  Introduction
      9.10.2. Financials
      9.10.3. Key Insights
      9.10.4. Key Strategy
      9.10.5. Product Portfolio
      9.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports